Follicular Thyroid Carcinoma

• CLINICAL_TRIALS trial_result · 2026-03-11
  Clinical Trial Update: Durvalumab Plus Tremelimumab for the Treatment of Patients With Progressive, Refractory Advanced Thyroid Carcinoma -The DUTHY Trial [Phase 2]

  Phase 2 trial evaluating durvalumab plus tremelimumab in progressive, refractory advanced thyroid carcinoma (papillary and follicular subtyp…

• CLINICAL_TRIALS trial_result · 2025-10-31
  Clinical Trial Update: Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer [Phase 2]

  Phase 2 trial update reports results from CaboNivoIpi (cabozantinib, nivolumab, ipilimumab) in advanced differentiated thyroid cancer, inclu…

• CLINICAL_TRIALS trial_result · 2025-08-24
  Clinical Trial Update: Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer [Phase 2]

  Phase 2 trial evaluating dabrafenib with or without trametinib in advanced differentiated thyroid carcinoma, including follicular, papillary…

• CLINICAL_TRIALS trial_result · 2025-04-22
  Clinical Trial Update: Radioiodine Planar and a SPECT/CT Imaging With Iodine-123 for Evaluation of Follicular Thyroid Nodules Prior to Surgery

  A Mayo Clinic study evaluating iodine-123 planar and SPECT/CT imaging to evaluate follicular thyroid nodules prior to surgery has completed.

• CLINICAL_TRIALS trial_result · 2025-04-01
  Clinical Trial Update: Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer [Phase 1]

  Phase 1 clinical trial evaluating Lutetium-177 DOTA-EB-FAPI in patients with metastatic, radioiodine-refractory thyroid cancer has completed…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2023-10-24
  Clinical Trial Update: Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) [Phase 2]

  A Phase 2 trial evaluating the combination of lenvatinib and pembrolizumab in differentiated thyroid cancers has completed, with results pos…

• CLINICAL_TRIALS trial_result · 2022-12-28
  Clinical Trial Update: Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer [Phase 2]

  Phase 2 trial evaluating trametinib for increasing tumoral iodine incorporation in patients with recurrent or metastatic thyroid cancer; res…

• CLINICAL_TRIALS trial_result · 2021-08-03
  Clinical Trial Update: Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer [Phase 2]

  Phase 2 trial evaluating whether adding selumetinib to radioactive iodine improves outcomes in patients with recurrent or metastatic thyroid…

• CLINICAL_TRIALS trial_result · 2021-07-15
  Clinical Trial Update: Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer [Phase 1, Phase 2]

  Clinical trial update for cediranib maleate with or without lenalidomide in thyroid cancer completed; results posted in 2021.

• CLINICAL_TRIALS trial_result · 2018-04-03
  Clinical Trial Update: Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer [Phase 2]

  Phase 2 trial of cabozantinib-s-malate in patients with refractory thyroid cancer has been completed, with results posted in 2018. The study…

• CLINICAL_TRIALS trial_result · 2017-09-15
  Clinical Trial Update: Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery [Phase 2]

  This Phase 2 trial evaluated Sunitinib malate in iodine-refractory thyroid cancers, including differentiated and medullary subtypes. Results…

• CLINICAL_TRIALS trial_result · 2017-03-15
  Clinical Trial Update: Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy [Phase 2]

  Phase 2 trial evaluating aflibercept in patients with recurrent or metastatic thyroid cancer that did not respond to radioactive iodine; the…

• CLINICAL_TRIALS trial_result · 2016-12-14
  Clinical Trial Update: A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin [Phase 2]

  Phase II trial evaluating valproic acid in patients with advanced thyroid cancers of follicular cell origin completed; results have been pos…

• CLINICAL_TRIALS trial_result · 2014-08-11
  Clinical Trial Update: Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer [Phase 2]

  Phase 2 trial evaluating the histone deacetylase inhibitor suberoylanilide hydroxamic acid (vorinostat) in patients with metastatic and/or l…

• CLINICAL_TRIALS trial_result · 2013-09-19
  Clinical Trial Update: A Drug-Drug Interaction Study of the Effects of XL184 (Cabozantinib) on Rosiglitazone in Subjects With Solid Tumors [Phase 1]

  Phase 1 study evaluating the drug-drug interaction between cabozantinib (XL184) and rosiglitazone in subjects with solid tumors; the trial h…